KIT and gastrointestinal stromal tumor: Using transcriptomic, genetic and pharmacologic approaches, we also demonstrate that the Hedgehog pathway predominantly activates KIT expression in human GIST and may be a cell viability factor in both imatinib-sensitive and imatinib-resistant GIST cell lines.